Skip to content

Medical-device intelligence

PQO: Anti-Müllerian Hormone Test System

FDA product code PQO: Anti-Müllerian Hormone Test System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PQO
FDA device name
Anti-Müllerian Hormone Test System
Device class
2
Regulation number
862.1092
Medical specialty
Clinical Chemistry
Review panel
TX

FDA definition

An Anti-Müllerian hormone test system is an in vitro diagnostic device intended to measure anti-Müllerian hormone in human serum and plasma. The test is intended to be used as an aid for assessing ovarian reserve in women.
Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 1 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Nov 13, 2017 to Nov 3, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PQO · Anti-Müllerian Hormone Test System41

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

5 matching records
Device / recordCompany in FDA recordSourceSource date
Female Fertility TestZ-0737-2026 · PQOGET TESTED INTERNATIONAL ABRecallDec 1, 2025FDA classification date
ADVIA Centaur® Anti-Müllerian Hormone (AMH)K221801 · PQOSiemens Healthcare Diagnostics, Inc.510(k)Jun 2, 2023FDA decision date
Access AMHK223679 · PQOBeckman Coulter, Inc.510(k)Feb 3, 2023FDA decision date
Elecsys AMHK203757 · PQORoche Diagnostics510(k)Jun 10, 2022FDA decision date
Access AMHK170524 · PQOBeckman Coulter, Inc.510(k)Nov 13, 2017FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗